3.連結財務諸表及び主な注記
(1)連結貸借対照表
|
|
|
|
|
|
|
|
|
|
|
|
(単位:千円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2025年8月31日)
|
当連結会計年度
(2026年8月31日)
|
|
資産の部
|
|
|
|
|
流動資産
|
|
|
|
|
|
現金及び預金
|
11,303,492
|
9,762,820
|
|
|
|
受取手形
|
123,237
|
103,479
|
|
|
|
売掛金
|
2,806,826
|
3,182,526
|
|
|
|
契約資産
|
13,077
|
77,149
|
|
|
|
商品及び製品
|
1,845,223
|
1,903,381
|
|
|
|
販売用不動産
|
2,312,911
|
2,329,464
|
|
|
|
仕掛品
|
1,240,402
|
1,452,376
|
|
|
|
原材料及び貯蔵品
|
1,624,115
|
1,969,087
|
|
|
|
その他
|
1,071,455
|
1,057,104
|
|
|
|
貸倒引当金
|
△15,667
|
△17,228
|
|
|
|
流動資産合計
|
22,325,077
|
21,820,162
|
|
|
固定資産
|
|
|
|
|
|
有形固定資産
|
|
|
|
|
|
|
建物及び構築物
|
23,139,121
|
25,328,646
|
|
|
|
|
|
減価償却累計額
|
△15,994,574
|
△16,670,336
|
|
|
|
|
|
建物及び構築物(純額)
|
7,144,546
|
8,658,309
|
|
|
|
|
機械装置及び運搬具
|
4,559,715
|
4,724,871
|
|
|
|
|
|
減価償却累計額
|
△3,457,409
|
△3,709,902
|
|
|
|
|
|
機械装置及び運搬具(純額)
|
1,102,305
|
1,014,968
|
|
|
|
|
土地
|
11,244,971
|
12,042,579
|
|
|
|
|
建設仮勘定
|
1,462,369
|
317,243
|
|
|
|
|
その他
|
1,385,378
|
1,376,710
|
|
|
|
|
|
減価償却累計額
|
△1,003,586
|
△1,063,748
|
|
|
|
|
|
その他(純額)
|
381,791
|
312,961
|
|
|
|
|
有形固定資産合計
|
21,335,985
|
22,346,062
|
|
|
|
無形固定資産
|
|
|
|
|
|
|
のれん
|
1,870,151
|
1,344,589
|
|
|
|
|
その他
|
148,765
|
196,552
|
|
|
|
|
無形固定資産合計
|
2,018,917
|
1,541,141
|
|
|
|
投資その他の資産
|
|
|
|
|
|
|
投資有価証券
|
568,050
|
1,227,691
|
|
|
|
|
繰延税金資産
|
170,073
|
145,998
|
|
|
|
|
その他
|
2,367,186
|
1,986,179
|
|
|
|
|
貸倒引当金
|
△58,376
|
△20,880
|
|
|
|
|
投資その他の資産合計
|
3,046,933
|
3,338,988
|
|
|
|
固定資産合計
|
26,401,835
|
27,226,193
|
|
|
資産合計
|
48,726,913
|
49,046,355
|
|
|
|
|
|
|
|
|
|
|
|
|
(単位:千円)
|
|
|
|
|
|
|
|
|
|
|
|
前連結会計年度
(2025年8月31日)
|
当連結会計年度
(2026年8月31日)
|
|
負債の部
|
|
|
|
|
流動負債
|
|
|
|
|
|
支払手形及び買掛金
|
3,623,087
|
3,251,276
|
|
|
|
短期借入金
|
9,472,879
|
9,968,879
|
|
|
|
1年内返済予定の長期借入金
|
8,964,611
|
8,829,207
|
|
|
|
未払法人税等
|
475,583
|
443,671
|
|
|
|
賞与引当金
|
197,241
|
235,007
|
|
|
|
契約負債
|
1,512,311
|
1,671,227
|
|
|
|
その他
|
1,746,850
|
1,424,587
|
|
|
|
流動負債合計
|
25,992,564
|
25,823,857
|
|
|
固定負債
|
|
|
|
|
|
長期借入金
|
5,475,080
|
4,612,712
|
|
|
|
繰延税金負債
|
215,709
|
205,001
|
|
|
|
役員退職慰労引当金
|
327,626
|
376,192
|
|
|
|
退職給付に係る負債
|
686,708
|
696,470
|
|
|
|
その他
|
828,825
|
896,292
|
|
|
|
固定負債合計
|
7,533,950
|
6,786,669
|
|
|
負債合計
|
33,526,515
|
32,610,527
|
|
純資産の部
|
|
|
|
|
株主資本
|
|
|
|
|
|
資本金
|
2,134,966
|
2,207,985
|
|
|
|
資本剰余金
|
2,651,225
|
2,681,182
|
|
|
|
利益剰余金
|
10,427,659
|
11,110,896
|
|
|
|
自己株式
|
△255,288
|
△78
|
|
|
|
株主資本合計
|
14,958,562
|
15,999,985
|
|
|
その他の包括利益累計額
|
|
|
|
|
|
その他有価証券評価差額金
|
50,467
|
91,589
|
|
|
|
為替換算調整勘定
|
12,043
|
58,570
|
|
|
|
退職給付に係る調整累計額
|
54,791
|
55,400
|
|
|
|
その他の包括利益累計額合計
|
117,302
|
205,559
|
|
|
新株予約権
|
594
|
-
|
|
|
非支配株主持分
|
123,938
|
230,282
|
|
|
純資産合計
|
15,200,398
|
16,435,828
|
|
負債純資産合計
|
48,726,913
|
49,046,355
|
E01064
29270
株式会社AFC-HDアムスライフサイエンス
AFC-HD AMS Life Science Co.,Ltd
通期第1号参考様式 [日本基準](連結)
Japan GAAP
true
cte
cte
2025-09-01
2026-08-31
FY
2026-08-31
2024-09-01
2025-08-31
2025-08-31
1
false
false
false
29270
2026-10-15
29270
2025-09-01
2026-08-31
29270
2025-09-01
2026-08-31
jppfs_cor:CapitalStockMember
29270
2025-09-01
2026-08-31
jppfs_cor:CapitalSurplusMember
29270
2025-09-01
2026-08-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
29270
2025-09-01
2026-08-31
jppfs_cor:NonControllingInterestsMember
29270
2025-09-01
2026-08-31
jpcrp_cor:OtherReportableSegmentsMember
29270
2025-09-01
2026-08-31
jpcrp_cor:ReconcilingItemsMember
29270
2025-09-01
2026-08-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
29270
2025-09-01
2026-08-31
jppfs_cor:RetainedEarningsMember
29270
2025-09-01
2026-08-31
jppfs_cor:ShareholdersEquityMember
29270
2025-09-01
2026-08-31
jppfs_cor:SubscriptionRightsToSharesMember
29270
2025-09-01
2026-08-31
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
29270
2025-09-01
2026-08-31
jppfs_cor:TreasuryStockMember
29270
2025-09-01
2026-08-31
tse-acedjpfr-29270:DepartmentStoreBusinessReportableSegmentMember
29270
2025-09-01
2026-08-31
tse-acedjpfr-29270:FoodServiceBusinessReportableSegmentMember
29270
2025-09-01
2026-08-31
tse-acedjpfr-29270:HealthCareReportableSegmentsMember
29270
2025-09-01
2026-08-31
tse-acedjpfr-29270:MedicalProductsReportableSegmentsMember
29270
2025-09-01
2026-08-31
tse-acedjpfr-29270:RealEstateAndConsignmentBusinessReportableSegmentMember
29270
2025-09-01
2026-08-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
29270
2025-09-01
2026-08-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
29270
2026-08-31
29270
2026-08-31
jppfs_cor:CapitalStockMember
29270
2026-08-31
jppfs_cor:CapitalSurplusMember
29270
2026-08-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
29270
2026-08-31
jppfs_cor:NonControllingInterestsMember
29270
2026-08-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
29270
2026-08-31
jppfs_cor:RetainedEarningsMember
29270
2026-08-31
jppfs_cor:ShareholdersEquityMember
29270
2026-08-31
jppfs_cor:SubscriptionRightsToSharesMember
29270
2026-08-31
jppfs_cor:TreasuryStockMember
29270
2026-08-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
29270
2026-08-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
29270
2024-09-01
2025-08-31
29270
2024-09-01
2025-08-31
jppfs_cor:CapitalStockMember
29270
2024-09-01
2025-08-31
jppfs_cor:CapitalSurplusMember
29270
2024-09-01
2025-08-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
29270
2024-09-01
2025-08-31
jppfs_cor:NonControllingInterestsMember
29270
2024-09-01
2025-08-31
jpcrp_cor:OtherReportableSegmentsMember
29270
2024-09-01
2025-08-31
jpcrp_cor:ReconcilingItemsMember
29270
2024-09-01
2025-08-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
29270
2024-09-01
2025-08-31
jppfs_cor:RetainedEarningsMember
29270
2024-09-01
2025-08-31
jppfs_cor:ShareholdersEquityMember
29270
2024-09-01
2025-08-31
jppfs_cor:SubscriptionRightsToSharesMember
29270
2024-09-01
2025-08-31
jpcrp_cor:TotalOfReportableSegmentsAndOthersMember
29270
2024-09-01
2025-08-31
jppfs_cor:TreasuryStockMember
29270
2024-09-01
2025-08-31
tse-acedjpfr-29270:DepartmentStoreBusinessReportableSegmentMember
29270
2024-09-01
2025-08-31
tse-acedjpfr-29270:FoodServiceBusinessReportableSegmentMember
29270
2024-09-01
2025-08-31
tse-acedjpfr-29270:HealthCareReportableSegmentsMember
29270
2024-09-01
2025-08-31
tse-acedjpfr-29270:MedicalProductsReportableSegmentsMember
29270
2024-09-01
2025-08-31
tse-acedjpfr-29270:RealEstateAndConsignmentBusinessReportableSegmentMember
29270
2024-09-01
2025-08-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
29270
2024-09-01
2025-08-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
29270
2025-08-31
29270
2025-08-31
jppfs_cor:CapitalStockMember
29270
2025-08-31
jppfs_cor:CapitalSurplusMember
29270
2025-08-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
29270
2025-08-31
jppfs_cor:NonControllingInterestsMember
29270
2025-08-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
29270
2025-08-31
jppfs_cor:RetainedEarningsMember
29270
2025-08-31
jppfs_cor:ShareholdersEquityMember
29270
2025-08-31
jppfs_cor:SubscriptionRightsToSharesMember
29270
2025-08-31
jppfs_cor:TreasuryStockMember
29270
2025-08-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
29270
2025-08-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
29270
2024-08-31
29270
2024-08-31
jppfs_cor:CapitalStockMember
29270
2024-08-31
jppfs_cor:CapitalSurplusMember
29270
2024-08-31
jppfs_cor:ForeignCurrencyTranslationAdjustmentMember
29270
2024-08-31
jppfs_cor:NonControllingInterestsMember
29270
2024-08-31
jppfs_cor:RemeasurementsOfDefinedBenefitPlansMember
29270
2024-08-31
jppfs_cor:RetainedEarningsMember
29270
2024-08-31
jppfs_cor:ShareholdersEquityMember
29270
2024-08-31
jppfs_cor:SubscriptionRightsToSharesMember
29270
2024-08-31
jppfs_cor:TreasuryStockMember
29270
2024-08-31
jppfs_cor:ValuationAndTranslationAdjustmentsMember
29270
2024-08-31
jppfs_cor:ValuationDifferenceOnAvailableForSaleSecuritiesMember
iso4217:JPY
xbrli:pure